{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:13Z","timestamp":1790800873655,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T17:59:36Z","timestamp":1619632776000},"page":"2989-2994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study"],"prefix":"10.1016","volume":"39","author":[{"given":"Francesco Paolo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Vittoria","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia Annatea","family":"Germinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.04.005_b0005","unstructured":"WHO. Poliomyelitis. Key facts. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/poliomyelitis. Last accessed on 24 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0010","unstructured":"CDC. What is Polio. Available from: https:\/\/www.cdc.gov\/polio\/what-is-polio\/hcp.html#poliovirus. Last accessed on 25 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0015","unstructured":"CDC. Pink book. Epidemiology and prevention of vaccine-preventable diseases. Poliomyelitis. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/polio.html#vaccines. Last accessed on 25 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0020","unstructured":"WHO. Biologicals. Oral polio vaccine (OPV). Available from: https:\/\/www.who.int\/biologicals\/areas\/vaccines\/polio\/opv\/en\/. Last accessed on 27 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0025","unstructured":"CDC. Vaccines and preventable diseases. Vaccine-derived poliovirus. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/polio\/hcp\/vaccine-derived-poliovirus-faq.html. Last accessed on 30 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0030","unstructured":"CDC. Vaccines and preventable diseases. Polio vaccination. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/polio\/index.html. Last accessed on 31 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0035","unstructured":"CDC. Vaccines and preventable diseases. Polio vaccine effectiveness and duration of protection. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/polio\/hcp\/effectiveness-duration-protection.html. Last accessed on 29 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0040","unstructured":"CDC. Who We Are: CDC and the global polio eradication initiative. Available from: https:\/\/www.cdc.gov\/polio\/who\/index.htm. Last accessed on 28 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0045","unstructured":"WHO. Global polio eradication initiative applauds WHO African region for wild polio-free certification. Available from: https:\/\/www.who.int\/news\/item\/25-08-2020-global-polio-eradication-initiative-applauds-who-african-region-for-wild-polio-free-certification. Last accessed on 24 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0050","doi-asserted-by":"crossref","unstructured":"Bandyopadhyay AS, Gast C, Rivera L, et al. Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial. Lancet Infect Dis 2020. Published Online October 23, 2020.","DOI":"10.1016\/S1473-3099(20)30555-7"},{"key":"10.1016\/j.vaccine.2021.04.005_b0055","unstructured":"Global Polio Eradication Initiative. Wild poliovirus list. List of wild poliovirus by country and year. Available from: http:\/\/polioeradication.org\/polio-today\/polio-now\/wild-poliovirus-list. Last accessed on 26 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0060","doi-asserted-by":"crossref","unstructured":"Crovari P. Public health history corner history of polio vaccination in Italy. IJPH - Year 8, Volume 7, Number 3, 2010","DOI":"10.2427\/5717"},{"key":"10.1016\/j.vaccine.2021.04.005_b0065","unstructured":"Italian ministry of health. Decree Law 7 June 2017, n. 73, Urgent provisions on vaccination prevention, as amended by the conversion law July 31, 2017]. Available from: http:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=60201. Last accessed on 23 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0070","unstructured":"Italian ministry of health. Vaccination in Italy. Vaccine coverage in Italy. Poliomyelitis. Available from: https:\/\/www.epicentro.iss.it\/vaccini\/dati_Ita. Last accessed on 31 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0075","unstructured":"WHO European Region. Certification of the Region\u2019s polio-free status in 2002. Available from: https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/poliomyelitis\/activities\/certification-and-maintenance-of-polio-free-status-in-the-european-region\/european-regional-commission-for-the-certification-of-poliomyelitis-eradication\/certification-of-the-regions-polio-free-status-in-2002. Last accessed on 21 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0080","unstructured":"The immunisation advisory centre. Efficacy and effectiveness. Available from: https:\/\/www.immune.org.nz\/vaccines\/efficiency-effectiveness. Last accessed on 24 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0085","unstructured":"WHO. Persistence of protective antibodies following immunization with OPV and IPV. Available from: https:\/\/www.who.int\/immunization\/polio_grad_duration_protection.pdf. Last accessed on 27 October 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0090","doi-asserted-by":"crossref","unstructured":"Tafuri S, Prato R, Martinelli D, et al. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect Dis. 2008;8:150. Published 2008 Oct 30.","DOI":"10.1186\/1471-2334-8-150"},{"key":"10.1016\/j.vaccine.2021.04.005_b0095","first-page":"1","article-title":"Long time persistence of antibodies against Mumps in fully MMR immunized young adults: an Italian retrospective cohort study","volume":"18","author":"Bianchi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.04.005_b0100","first-page":"44","article-title":"Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis","author":"WHO","year":"1990","journal-title":"Geneva; WHO"},{"issue":"3","key":"10.1016\/j.vaccine.2021.04.005_b0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/21645515.2018.1547608","article-title":"Assessment of seroprevalence against poliovirus among Italian adolescents and adults","volume":"15","author":"Lupi","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2021.04.005_b0110","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1080\/21645515.2018.1475812","article-title":"Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence","volume":"14","author":"Giammanco","year":"2018","journal-title":"Italy Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2021.04.005_b0115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ajic.2019.09.024","article-title":"Compliance with immunization and a biological risk assessment of health care workers as part of an occupational health surveillance program: The experience of a university hospital in southern Italy","volume":"48","author":"Bianchi","year":"2020","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.vaccine.2021.04.005_b0120","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1186\/s12889-019-7829-3","article-title":"Immunity to rubella: an Italian retrospective cohort study","volume":"19","author":"Bianchi","year":"2019","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2021.04.005_b0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/infdis\/jiz508","article-title":"Long-term immunogenicity of measles vaccine: An Italian retrospective cohort study","volume":"221","author":"Bianchi","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.04.005_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jvh.13001","article-title":"HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students","volume":"26","author":"Bianchi","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2021.04.005_b0135","article-title":"Immunity status against poliomyelitis in childbearing women in a province of northern Italy. A cross-sectional analysis","author":"Veronesi","year":"2013","journal-title":"Ann Ig"},{"issue":"8","key":"10.1016\/j.vaccine.2021.04.005_b0140","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00054-12","article-title":"Seroepidemiology of polioviruses among university students in northern Italy","volume":"19","author":"Baldo","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2021.04.005_b0145","doi-asserted-by":"crossref","unstructured":"Tafuri S, Chironna M, Martinelli D, Sallustio A, Prato R, Germinario C. Surveillance of poliovirus circulation among refugees in Italy, 2008-2011. J Travel Med. 2012 Jan-Feb;19(1):61-3.","DOI":"10.1111\/j.1708-8305.2011.00571.x"},{"key":"10.1016\/j.vaccine.2021.04.005_b0150","unstructured":"Germinario C, Gallone MS, Tafuri S. Migrant health: the Apulian model. Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):76-80."},{"key":"10.1016\/j.vaccine.2021.04.005_b0155","unstructured":"Italian Ministry of Health. Acute flaccid paralysis surveillance. Available from: http:\/\/www.salute.gov.it\/portale\/malattieInfettive\/dettaglioContenutiMalattieInfettive.jsp?lingua=italiano&id=820&area=Malattie%20infettive&menu=sorveglianza#:~:text=Il%20sistema%20di%20sorveglianza%20delle%20Paralisi%20Flaccide%20acute%20(PFA)%2C,mostrano%20sintomatologia%20identica%20alla%20polio. Last accessed on 01 November 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0160","unstructured":"Italian Ministry of Health. National Plan of Vaccinal Prevention (PNPV) 2017-2019. Available from: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf. Last accessed on 03 November 2020."},{"key":"10.1016\/j.vaccine.2021.04.005_b0165","first-page":"47","article-title":"Polio control after certification: major issues outstanding","volume":"82","author":"Fine","year":"2004","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:47Z","timestamp":1759402667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":33,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21004308"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}